🇺🇸

M&A Activity

· daily

US Merger & Acquisition SEC Filings — May 07, 2026

A surge in SPAC IPO activity dominates the 19 filings, with 7 blank-check companies (Irenic, ARC Group, Mountain Crest, RRE Ventures, Forefront Tech, GP-Act III) completing IPOs raising aggregate ~$883M at $10/unit, signaling robust appetite for de-SPAC opportunities amid extended deadlines to Nov/July 2026. Energy sector consolidation peaks with Devon Energy completing undisclosed asset acq/disposition and Coterra merger (0.70 Devon shares/share), leading to delisting and cessation of reporting, while VSE Corp's $2.025B PAG aviation acq boosts pro forma 2025 revenue ~50% and targets >20% EBITDA margins. Media (Gray $171M stations) and construction (Suncrete Nelson Bros acq) show accretive bolt-ons expanding footprints, contrasted by Carnival's high-risk restructuring (delisting, control change) and neutral filings lacking details (Sculptor, Shuttle). No broad YoY/QoQ declines noted, but increased debt (VSE $900M Term Loan B, Acura $10.3M principal) and dilutions (Blue Acq 12% incentive pool) emerge; positive sentiments in 9/19 filings drive M&A momentum. Portfolio trend: Acquisitions accretive across sectors (avg implied revenue lift 30-50%), SPAC trust funding intact for catalysts.

19 high priority 19 total filings
· daily

US Merger & Acquisition SEC Filings — May 06, 2026

The 15 filings reveal a surge in SPAC activity with multiple IPOs (Plutonian $100M, Quantum Leap $200M), unit separations, and deadline extensions (GP-Act III to Nov 2026, Legato to Aug 2026), signaling robust blank check company fundraising amid M&A appetite. Key M&A/takeover highlights include Broadwind's $19.5M facility sale and pivot to precision manufacturing, 908 Devices' NIRLAB acquisition with raised FY2026 revenue guidance to $67-70M (19-25% growth), Nuveen Churchill funds' $347M asset swap, and Brookfield's $1.2B takeover of Peakstone Realty Trust. Period-over-period trends show revenue growth in operating companies (908 Devices +14% YoY to $13.4M, Ascent +9% YoY to $19.4M) but margin pressures (Ascent -272bps to 14.5%, 908 gross +400bps to 51% offset by wider $12M net loss). Mixed sentiments dominate earnings/divestitures, with SPACs neutral-to-positive and compliance risks emerging. Portfolio-level pattern: 7/15 filings involve SPAC lifecycle events, 5 M&A transactions, indicating heightened US takeover activity but with execution risks like high redemptions and guidance withdrawals.

15 high priority 15 total filings
· daily

US Merger & Acquisition SEC Filings — May 05, 2026

The 16 filings reveal a surge in SPAC activity with 8 new IPOs, extensions, unit separations, and de-SPAC mergers targeting tech, AI, healthcare, logistics, and biofuels, signaling robust M&A momentum in high-growth sectors amid a May 2026 filing cluster. Key period-over-period trends include Avista Corp's Q1 2026 GAAP net income up 16% YoY to $92M ($1.11/share) and non-GAAP utility earnings up 11% to $91M, though electric margins dipped slightly QoQ; limited other operational comps highlight deal-driven focus over earnings. Critical developments feature Compass Diversified's $292.5M subsidiary sale for deleveraging to <1.0x leverage by June 30, multiple $60-105M SPAC IPOs, and high-value mergers like DMAA-PAGC at $1B EV and Applied Digital's 97%-owned ChronoScale spin-off. Portfolio-level patterns show positive sentiment in 9/16 filings (avg materiality 8.3/10), with SPACs dominating (50% of filings) and M&A completions/announcements in AI/data centers/biofuels, implying investor appetite for tech consolidation despite redemption risks in extensions like Pyrophyte's $1.29M outflow. Capital allocation leans toward deleveraging (CODI) and reinvestment via acquisitions (Exodus $30M, Oncotelic $20M IP), with no dividend/buyback shifts noted. Market implications: heightened takeover premiums and SPAC dry powder could drive 10-20% upside in targets, but monitor redemptions and leverage covenants.

16 high priority 16 total filings
· daily

US Merger & Acquisition SEC Filings — May 04, 2026

The 18 filings reveal a surge in US M&A and takeover activity dominated by SPAC IPOs, de-SPAC approvals, and completed acquisitions across sectors like logistics, defense/AI, beverages, biotech, banking, and homebuilding, with 6 new SPAC-related IPOs/pricings and 5 deal completions signaling robust dealmaking in May 2026. Positive sentiment prevails in 12/18 filings, driven by unanimous board approvals, large IPO sizes ($100M-$350M), and strategic acquisitions enhancing footprints (e.g., SunOpta delisting post-$6.50/share buyout, Gyre's $300M all-stock Cullgen deal). Key period trends include GBTG's Q1 revenue +35% YoY (7% ex-acqs) but margin contraction (-410 bps gross, -490 bps EBITDA) amid a pending acquisition; no broad insider selling/buying noted, but capital allocation favors trust deposits for SPAC extensions (e.g., $13.9K-$498 into trusts). Portfolio-level patterns show SPACs extending deadlines (3 cases) or approving mergers with low/no redemptions (e.g., Willow Lane $134.5M trust intact), contrasting one termination and Nasdaq compliance risks. Implications: heightened M&A liquidity for targets, but execution risks from redemptions (19.6M in AParadise) and regulatory hurdles; watch SPAC closings by Q3 2026 for de-SPAC catalysts.

18 high priority 18 total filings
· daily

US Merger & Acquisition SEC Filings — May 01, 2026

The 15 filings reveal heightened M&A and takeover activity in US markets, with 8 completions or announcements including bank mergers (Burke & Herbert/LINKBANCORP), energy acquisitions (Diversified Energy $248M), IP deals (Lunai Bioworks $20M valuation), and SPAC mergers (GalaxyEdge/Rongcheng $350M pre-money), signaling robust deal flow despite SPAC extensions in 4 cases. SPAC maneuvers dominate with 1 IPO ($250M RRE Ventures), 3 deadline extensions (Live Oak to Jul 15 2026, Drugs Made In America/AltEnergy to 2027), and management shifts (Bleichroeder). Period trends show WisdomTree's standout AUM +5.6% QoQ to $152.6B and revenues +47.5% YoY, contrasting Crown Castle's FY2026 guidance for AFFO growth ~$65M midpoint despite site rentals -~$200M YoY. Capital allocation shines with Crown Castle's $1B buyback + $7B debt cut post-$8.5B divestitures, WisdomTree's $0.03 dividend, and Diversified's debt-funded expansion. Portfolio-level patterns indicate financial services consolidation (2/15 bank-related), energy/biotech/AI tuck-ins, and SPAC persistence amid Nasdaq pressures (Quetta deficiency). Implications favor pure-play refinancings and post-merger footprints, but flag SPAC dilution risks and compliance hurdles.

15 high priority 15 total filings
· daily

US Merger & Acquisition SEC Filings — April 30, 2026

Across 9 US M&A filings on April 30, 2026, a surge in transaction completions dominates, with 4 divestitures generating ~$2.4B in cash proceeds (SM Energy $950M, Spire $215M, Perrigo €306M net, Golden $2.75/share dividend), funding debt reduction, redemptions, and acquisitions amid portfolio streamlining. Positive sentiment prevails in 5/9 cases (SM Energy, Spire, Perrigo, Plutonian SPAC IPO, Bakkt acquisition), contrasting mixed/neutral in mergers involving dilutions or spin-outs (Golden, SOBR Safe 98% dilution, Coeptis pro forma op loss worsening YoY). Period comparisons highlight Coeptis Therapeutics' pro forma 2025 net loss improvement to $(9.1M) from $(12.3M) but operating loss deterioration to $(10.0M) from $(5.1M) YoY, signaling persistent unprofitability post-spin-out. SPAC activity intensifies with Plutonian's $100M IPO and SIM's deadline extension to 2027, while energy firms (SM, Spire) advance $1B+ divestiture targets. Capital allocation trends favor debt deleveraging (SM $819M notes redemption, Perrigo debt reduction) over dividends/buybacks, implying fortified balance sheets but limited shareholder returns. Market implications include alpha from post-M&A catalysts like redemptions and approvals, with watch for Q3 2026 closings amid high materiality (avg 8.7/10).

9 high priority 9 total filings
· daily

US Merger & Acquisition SEC Filings — April 29, 2026

The 9 filings reveal a surge in SPAC M&A activity, with 7/9 involving acquisition corporations at various stages: new IPO (Irenic), completed no-redemption milestone (Willow Lane), extensions (GP-Act III adjourned to May 6, Constellation to May 29), updated presentations (D. Boral ARC, Spring Valley), and financing (UY Scuti note). Suncrete completed a strategic acquisition of Hope Concrete, expanding into Texas/Louisiana with retained expert operators, signaling construction sector consolidation in Sunbelt. Green Brick reported mixed Q1 2026 results with net income -18.8% YoY to $60.9M, revenues -5.9% YoY, but standout 28.9% gross margins (highest among peers, +320 bps adjusted) and 95.2% YoY financial services growth; share repurchases of $7.2M underscore confidence amid backlog drop (-34.8% YoY). Overarching themes include SPAC deadline pressures with mixed shareholder support, positive deal completions/progress, and no broad insider activity noted. Portfolio-level: SPACs dominate (78%), construction M&A active; implications favor monitoring catalysts like adjourned votes and S-4 progress for de-SPAC upside, while Green Brick's restatement (no net income impact) warrants scrutiny.

9 high priority 9 total filings
· daily

US Merger & Acquisition SEC Filings — April 28, 2026

A cluster of 11 8-K filings on April 28, 2026, highlights intense M&A and takeover activity dominated by SPAC/acquisition corporations, with 10/11 exhibiting elevated risks including delisting notices and director departures, signaling widespread distress and potential deal unwindings in the blank-check sector. Positive outliers include SEMrush Holdings completing an acquisition with a streamlined charter amendment to 100,000 shares of single-class common stock and Pioneer Bancorp's accretive $140M acquisition of Targeted Lending, adding a $120M loan portfolio and nationwide equipment financing capabilities. No explicit period-over-period financial trends (revenue, margins) are reported across filings, but portfolio-level patterns show high average materiality (7.6/10) and risk levels (6/11 medium-high), with neutral-to-positive sentiment only in SEMrush (neutral) and Pioneer (positive). Director departures in 4/11 filings (Arcellx, Roman DBDR II, Urgent.ly, implied others) suggest management instability amid post-merger challenges. Implications: Avoid SPAC exposure due to delisting risks; favor operational firms like Pioneer for M&A-driven growth. Overall, themes point to SPAC sector contraction contrasting with selective tuck-in deals in banking/tech services.

11 high priority 11 total filings
· daily

US Merger & Acquisition SEC Filings — April 27, 2026

The 12 filings reveal a surge in SPAC-driven M&A activity, with 8/12 (67%) involving SPACs at various stages: 3 business combinations announced (Miluna/CADV.AI at $300M pre-money, Aerkomm/Ejectt via 65M shares, AParadise/Enhanced), 3 extensions (Charlton Aria to July 2026, International Media 17th extension to June 2026), promissory notes (Andretti, Keen Vision), governance updates (Dune II), and IPO success (QuasarEdge full over-allotment adding $15M). Two major completed deals: BioMarin/Amicus $4.8B all-cash adding Fabry/Pompe assets, and Focus Universal real property acquisition; Amicus post-merger governance. Positive sentiment in 4/12 (33%), neutral 7/12, mixed 1/12; no explicit YoY/QoQ declines but SPAC extensions signal prolonged target searches vs. swift closings in non-SPACs. Forward-looking catalysts cluster in H2 2026 (Miluna close, extensions), with BioMarin guidance May 4, 2026. Implications: heightened M&A pipeline supports takeover premiums, but SPAC delays risk redemptions; pharma consolidation accelerates rare disease growth.

12 high priority 12 total filings
· daily

US Merger & Acquisition SEC Filings — April 24, 2026

The 11 filings reveal a vibrant US M&A and takeover landscape dominated by SPAC activities (7/11 filings), including fresh IPOs, extensions, leadership transitions, and conditional listings, alongside four high-impact acquisitions in robotics, defense, pharma, and real estate finance. Key period-over-period trends highlight explosive growth in acquired entities: ASA Robotics revenue +213% YoY to HK$1.6M with margins expanding +5040 bps to 60.5%, Ondas backlog surging 160% to $457M pro forma, and Apollo CRE realizing $2.2B cash post-portfolio sale at a premium to trading levels. M&A completions (International Endeavors, Telomir, Ondas, Apollo) deliver strategic synergies, backlog boosts, and liquidity, signaling portfolio-level conviction in tech/defense/pharma sectors. SPAC maneuvers indicate ongoing deal hunting amid tight timelines, with extensions and amendments buying time for business combinations. Overall, bullish sentiment prevails (6/11 positive), pointing to actionable opportunities in post-merger entities and de-SPAC catalysts, though leadership churn and listing risks warrant caution.

11 high priority 11 total filings
· daily

US Merger & Acquisition SEC Filings — April 23, 2026

The 9 filings reveal a vibrant SPAC and M&A landscape on April 23, 2026, dominated by lifecycle extensions (4/9 companies), asset acquisitions (3/9), PIPE financings, and one high-profile liquidation, signaling persistent deal-making amid deadline pressures. Positive sentiments prevail in 4/9 cases, driven by data center buys, sports betting acquisitions, and $32M recycling PIPE, contrasting ESH's dissolution; no broad YoY revenue/margin trends emerge, but capital inflows via trust deposits ($125k-$50k notes) and share issuances highlight liquidity support for combos. Insider conviction shines in Cayson deposits and promissory notes, with forward-looking catalysts clustering in May-June 2026 closings/extensions to 2027. Portfolio-level pattern: 6/9 SPACs actively extending/pursuing targets, implying sector resilience but elevated liquidation risk (1/9 materialized). Market implications include alpha in pre-close assets (e.g., 3MW data center) and PIPE-backed mergers, while monitoring governance shifts in Motorsport/Day One for takeover confirmations. Overall, M&A activity skews bullish for tech/data/recycling niches, with extensions buying time versus outright failures.

9 high priority 9 total filings
· daily

US Merger & Acquisition SEC Filings — April 22, 2026

The 11 filings highlight intense SPAC lifecycle activity in US M&A, with 1 fresh $100M IPO (QuasarEdge), 3 advancing business combinations (Iron Horse $250M+ AI battery deal, Allegro warrant support for SeeQC merger, Constellation HiTech webinar), 4 deadline extensions/postponements (TLGY to July 2026, Pyrophyte trust at $19.5M seeking further extension, SIM EGM delayed to May 1 2026, Everest interest withdrawal amendment), 1 merger termination (Oak Woods), 1 Nasdaq compliance risk (Flag Ship late 10-K), and 1 completed takeover (First Eagle acquires Diamond Hill at $175/share, pro forma AUM $213B). No operational revenue/margin trends available as most are pre-revenue SPACs, but trust account stability is key metric with Pyrophyte at $12.91/share redemption value and full extension deposits made. Positive themes dominate in tech/AI/minerals deals amid prolonged searches, but risks of liquidation/Nasdaq delisting loom for laggards. Portfolio-level pattern: 7/11 filings show extension efforts or new capital (vs 2 failures), implying sector resilience but extended timelines to H2 2026/2027 closings. Market implication: Opportunities in de-SPAC targets like Electra AI battery (backed by Stellantis/Ferrari), while monitor redemptions and compliance.

11 high priority 11 total filings
· daily

US Merger & Acquisition SEC Filings — April 21, 2026

The 13 filings reveal a bifurcated US M&A landscape dominated by SPAC activity (9/13 filings), with fresh IPOs from JATT II ($60M healthcare-focused), APEX Tech (over-allotment full exercise adding $3M), and Maywood 2 ($100M) signaling renewed investor appetite amid no prior period comparisons indicating baseline launches, contrasted by distress in aging SPACs like PHP Ventures (extension contributions cut ~80% from $4,771 to $957/month), Pyrophyte (third extension deposits), Charlton Aria, and Quetta (delisting risks). Operating company M&A highlights include NEXGEL's accretive Celularity acquisition tripling pro-forma annual revenue to $35M with immediate profitability boost and three 510(k) filings planned 2026-2028, XMax's $5.45M investment yielding >99.9% stake in SpaceX-holding fund, and CVB Financial's merger with Heritage scaling assets >$20B, loans ~$12B, deposits ~$17B to become a top-10 California bank holding company. No broad insider trading or dividend/buyback trends reported across filings, but capital locked in SPAC trusts (~$100M+ each for new IPOs) underscores dry powder for future deals; sentiment skews positive (7/13) with high materiality deals (avg 7.7/10). Portfolio-level pattern: SPAC extensions/delays average 3-4 months YoY without business combinations, flagging sector fatigue, while banking consolidation offers scale-driven outperformance. Forward catalysts cluster in late April-May 2026, prioritizing M&A execution over SPAC launches.

13 high priority 13 total filings
· daily

US Merger & Acquisition SEC Filings — April 20, 2026

The six filings highlight a surge in SPAC-related M&A activity and corporate restructurings within the USA M&A & Takeover stream, with 4/6 involving SPACs (mergers, extensions, financing, compliance). A standout $280M enterprise value de-SPAC with Tigerless Health and a biotech spin-off unlocking value via AnaptysBio (now >95% EBIT margin, $140-145M net cash) and First Tracks ($180M cash, 2-year runway) dominate positive developments. No period-over-period declines or flat operational metrics reported across filings where specified (e.g., First Tracks), contrasting with YHN's Nasdaq non-compliance. Forward-looking catalysts cluster in H2 2026, including deal closes and compliance deadlines. Portfolio-level trends show SPAC persistence amid liquidity support, with positive sentiment in 5/6 filings implying near-term listing opportunities and value separation, though delisting risks loom for underperformers. Overall, actionable alpha from spin-off pure-plays and SPAC resolutions outweighs isolated distress signals.

6 high priority 6 total filings
· daily

US Merger & Acquisition SEC Filings — April 17, 2026

The 'USA M&A & Takeover Activity' stream reveals a surge in SPAC-related developments across 10 filings, with 7/10 involving blank check companies announcing IPOs, mergers, extensions, or structural changes, signaling robust M&A momentum in 2026. Key themes include successful SPAC IPOs (QuasarEdge raising $115M total), definitive business combinations (Viking-NorthStar at $300M pre-money, Sizzle-Trasteel), and deadline extensions (Israel Acquisitions to May 15, Bayview to May 19), indicating persistent deal-making despite some delays. FFIN's Q1 results show banking sector resilience with 16.6% YoY net income growth and 13.5% NII rise, but QoQ asset declines highlight deposit pressures. Positive sentiment dominates (5/10 filings), with mixed/neutral in earnings and stalled deals; no insider selling patterns noted, but capital deployments into trusts support ongoing pursuits. Forward-looking catalysts cluster in Q3 2026 (Viking close) and May 2026 extensions, positioning SPACs for de-SPAC upside. Portfolio-level trend: 6/10 filings report no declines, emphasizing growth via M&A over organic trends.

10 high priority 10 total filings
· daily

US Merger & Acquisition SEC Filings — April 16, 2026

Across four US SEC filings in the M&A & Takeover stream, themes center on SPAC lifecycle extensions and separations (2/4 filings), a biotech asset acquisition with mixed Phase 3 data, and a radioisotope producer's financing amid deepening losses. Period-over-period trends show stark contrasts: Ionetix revenue surged 67.7% YoY to $6.0M for FY2025 but net loss widened 32.0% YoY to $39.7M, cash plummeted 94.6% to $0.3M, and assets fell 11.6% to $35.0M; MeiraGTx's acquisition highlights strong secondary endpoints (e.g., p=0.006 LLQ PRO mobility) despite primary endpoint miss. SPACs Compass and SUMA extended timelines to July 2026 and enabled unit separations from April 20, 2026, signaling prolonged target hunts in tech-enabled sectors. Mixed/neutral sentiments dominate (3/4), with high materiality in Ionetix (going concern doubts) and MeiraGTx ($25M J&J deal for 2027 launch). Portfolio-level patterns indicate resilient M&A pursuit amid liquidity pressures, with biotech outliers in asset deals and SPACs comprising 50% of activity, implying near-term catalysts in business combinations.

4 high priority 4 total filings
· daily

US Merger & Acquisition SEC Filings — April 15, 2026

Across 9 SPAC filings in USA M&A & Takeover Activity, a dominant theme is deadline extensions and amendments in 6/9 cases (Pantages, Keen Vision, Ribbon, SIM, WinVest, indirectly Spring Valley), signaling sponsor commitment amid no completed deals, with total extension funding ~$335k via trust deposits and notes. Positive outliers include board expertise addition at Launchpad Cadenza and strategic tailings acquisition for Plum III's rare earth project (1.5M tons for 3M shares), contrasting mixed risks in Spring Valley's fusion merger. No YoY/QoQ operating trends available as pre-merger entities, but capital allocation trends show increasing sponsor loans/deposits (e.g., Ribbon $125k, WinVest $180k note with $60k drawn). Neutral-to-positive sentiment prevails (2 positive, 6 neutral, 1 mixed), with materiality highest (8/10) for active M&A updates. Portfolio-level pattern: SPAC sector under deadline pressure (original deadlines April-May 2026), driving activity spikes; implications include short-term upside on catalyst hits but redemption risks if unfulfilled. Forward-looking catalysts cluster late April, positioning for de-SPAC announcements.

9 high priority 9 total filings
· daily

US Merger & Acquisition SEC Filings — April 14, 2026

The 13 filings reveal a surge in SPAC activity dominating USA M&A & Takeover space, with 3 new IPOs (Maywood, Apogee, ACP) raising ~$487M gross proceeds in early April 2026, alongside 2 de-SPAC completions (Horizon-Monroe merger closing with $471.7M pro forma assets; Haymaker-Suncrete despite pre-merger $31.5k net losses and going concern doubts). Key period trends include Assertio's pro forma continuing ops revenue +9.7% YoY to $68.2M (2025 vs 2024) but net loss widening 14.2% YoY to $31.3M, offset by $35M asset sale boosting cash to $45.2M and equity to $109.5M; discontinued ops showed $50.5M rev/$11.4M NI pre-sale. Positive sentiments prevail (7/13 positive/neutral), with Horizon announcing $10M buyback, supplemental distributions from July 2026, and $4M fee waivers. Portfolio-level patterns: SPAC fundraising liquidity up ~487M enabling targets in robotics/EVs/fintech; BDC consolidation via Horizon-Monroe adds $24B AUM. Implications: Heightened M&A catalysts short-term, watch SPAC deadlines (e.g., Suncrete July 28) and post-merger integrations for alpha.

13 high priority 13 total filings
· daily

US Merger & Acquisition SEC Filings — April 13, 2026

A remarkable surge in USA M&A and takeover activity on April 13, 2026, with 11 filings dominated by SPAC business combinations and asset acquisitions in high-growth AI sectors including fintech lending, healthcare analytics, defense detection, and video intelligence. Five positive-sentiment deals (IVCA-Blue Finance $220M, Sizzle-Trasteel $800M, CCTC AI IP, PHGE-DFSL defense, VWAV-xClibre $60M IP) highlight bullish M&A momentum, with no reported YoY/QoQ financial declines but forward-looking earnouts and milestones signaling growth potential. Neutral filings reflect SPAC lifecycle pressures like 3 extensions (Future Vision II $191K note, Inception $12K deposit) and 1 adjournment (Ribbon to Sep 2026), indicating sponsor commitment amid deadline risks but no insider selling or capital cuts. High materiality averages 7/10, with portfolio-level pattern of AI-themed takeovers (4/11 filings) vs routine SPAC housekeeping (4/11). Market implications: Elevated pre-close volatility for SPACs, alpha in AI M&A targets; no sector-wide margin compression or ratio deteriorations noted. Catalyst calendar dense with shareholder votes, F-4 filings, and H2 2026 POCs.

11 high priority 11 total filings
· daily

US Merger & Acquisition SEC Filings — April 10, 2026

The 14 filings reveal a surge in SPAC activity with 5 new IPOs/extensions/appointments signaling renewed M&A appetite in blank-check vehicles targeting tech, private credit, and advanced materials, amid 3 director resignations and 1 delisting highlighting sector churn. Actual M&A progressed with BiomX's acquisition of Zorronet (AI defense tech) from Nukkleus, FG Merger's Boxabl deal extension to July 31, 2026, and Compass Digital's merger with Key Mining, while Ashford Hospitality's $40.5M hotel sale improved pro forma operating income 18.5% YoY to $137.9M and narrowed net loss 10.7% to $(191.8M). Jet.AI's 1-for-200 reverse split reduced shares 99.5% to maintain Nasdaq compliance, freeing shares for potential future deals. No broad insider trading activity noted, but board additions in Iron Horse, T-REX convey management conviction; sentiments skew positive/neutral (10/14) with SPAC governance tweaks dominating. Portfolio-level trends show asset sales/debt reductions enhancing balance sheets (e.g., Ashford net debt -1.6% pro forma), positioning for M&A catalysts. Distressed signals in Quetta (MVLS failure post-180 days) contrast bullish IPO momentum ($350M+ raised), implying selective opportunities in dealflow-ready SPACs vs. fading ones.

14 high priority 14 total filings